ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival

European Journal of Cancer

Volumn 43, Issue 6, 2007, Pages 1023-1029

  Karakiewicz, Pierre I ^a   Trinh, Quoc Dien ^a   de la Taille, Alexandre ^b   Abbou, Claude C ^b   Salomon, Laurent ^b   Tostain, Jacques ^c   Cindolo, Luca ^d   Artibani, Walter ^e   Ficarra, Vincenzo ^e   Patard, Jean Jacques ^f  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d G RUMMO HOSPITAL   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

ECOG; Prognosis; Renal cell carcinoma; Survival; Symptoms

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ELECTROCORTICOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SAFETY; SCHOOL CHILD; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, RENAL CELL; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 33947586320     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.01.020     Document Type: Article

References (27)

1. Patard J.J., Rioux-Leclercq N., and Fergelot P. Understanding the importance of smart drugs in renal cell carcinoma. Eur Urol 49 (2006) 633-643
2. Stadler W.M. Targeted agents for the treatment of advanced renal cell carcinoma. Cancer 104 (2005) 2323-2333
3. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
4. Kattan M.W., Reuter V., Motzer R.J., Katz J., and Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
5. Yaycioglu O., Roberts W.W., Chan T., Epstein J.I., Marshall F.F., and Kavoussi L.R. Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model. Urology 58 (2001) 141-145
6. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19 (2001) 1649-1657
7. Cindolo L., de la Taille A., Messina G., et al. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int 92 (2003) 901-905
8. Motzer R.J., Mazumdar M., Bacik J., Berg W., Amsterdam A., and Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17 (1999) 2530-2540
9. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
10. Flanigan R.C., Salmon S.E., Blumenstein B.A., et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345 (2001) 1655-1659
11. Mickisch G.H., Garin A., van Poppel H., de Prijck L., and Sylvester R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358 (2001) 966-970
12. Patard J.J., Leray E., Rodriguez A., Rioux-Leclercq N., Guille F., and Lobel B. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 44 (2003) 226-232
13. Patard J.J., Leray E., Cindolo L., et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172 (2004) 858-862
14. Greene F.L., American Joint Committee on Cancer, and American Cancer Society. AJCC cancer staging manual (2002), Springer, New York
15. Chun F.K., Briganti A., Jeldres C., et al. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy. Eur Urol (2006)
16. Elson P.J., Witte R.S., and Trump D.L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48 (1988) 7310-7313
17. Mallah K.N., DiBlasio C.J., Rhee A.C., Scardino P.T., and Kattan M.W. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 103 (2005) 2030-2034
18. Karakiewicz P.I., Lewinshtein D.J., Chun F.K., et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol (2006)
19. Graefen M., Ohori M., Karakiewicz P.I., et al. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J Urol 171 (2004) 200-203
20. Kattan M.W. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 95 (2003) 634-635
21. Bleumer I., Oosterwijk E., De Mulder P., and Mulders P.F. Immunotherapy for renal cell carcinoma. Eur Urol 44 (2003) 65-75
22. Negrier S., Escudier B., Lasset C., et al. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie. N Engl J Med 338 (1998) 1272-1278
23. Miller D.C., Hollingsworth J.M., Hafez K.S., Daignault S., and Hollenbeck B.K. Partial nephrectomy for small renal masses: an emerging quality of care concern?. J Urol 175 (2006) 853-857 discussion 858
24. Chan D.Y., Cadeddu J.A., Jarrett T.W., Marshall F.F., and Kavoussi L.R. Laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. J Urol 166 (2001) 2095-2099 discussion 2099-100
25. Pantuck A.J., Zisman A., and Belldegrun A.S. The changing natural history of renal cell carcinoma. J Urol 166 (2001) 1611-1623
26. Hollingsworth J.M., Miller D.C., Daignault S., and Hollenbeck B.K. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98 (2006) 1331-1334
27. Marumo K., Satomi Y., Miyao N., et al. The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997. Int J Urol 8 (2001) 359-365